IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
23 hedge funds and large institutions have $601K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+6
Holders Change %
+35.29%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $256K | +$108K | +431,500 | +73% |
|
2
Citadel Advisors
Miami,
Florida
| $99K | +$99K | +394,655 | New |
|
3
Millennium Management
New York
| $94K | +$94K | +376,944 | New |
|
|
VF
4
Virtu Financial
New York
| $58K | +$9.57K | +38,243 | +20% |
|
|
WS
5
Wedbush Securities
Los Angeles,
California
| $22K | – | – | – |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $20K | +$20K | +79,566 | New |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $17K | +$17K | +66,459 | New |
|
|
TSS
8
Two Sigma Securities
New York
| $10K | +$10K | +39,231 | New |
|
|
FAAS
9
First Allied Advisory Services
San Diego,
California
| $10K | +$10K | +40,000 | New |
|
10
UBS Group
Zurich,
Switzerland
| $8K | +$2.86K | +12,035 | +56% |
|
11
Bank of New York Mellon
New York
| $7K | +$7K | +26,335 | New |
|
|
APA
12
American Portfolios Advisors
Holbrook,
New York
| $1 | – | – | – |
|
|
RE
13
RBC Europe
London,
United Kingdom
| $1 | – | – | – |
|
|
14
Goldman Sachs
New York
| – | -$8K | -24,166 | Closed |
|
|
15
Geode Capital Management
Boston,
Massachusetts
| – | -$3K | -10,995 | Closed |
|